003720.KS
SamYoung Chemical Co.,Ltd [003720.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
003720.KS Stock Summary
Top 10 Correlated Stocks
003720.KS
In the News
003720.KS Financial details
Company Rating
Buy
Market Cap
133.32B
Income
18.63B
Revenue
122.59B
Book val./share
2010.56
Cash/share
362.57
Dividend
-
Dividend %
-
Employees
176
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
51.69
Forward P/E
-
PEG
0.31
P/S
1.15
P/B
3.02
P/C
10.65
P/FCF
-11.62
Quick Ratio
-
Current Ratio
0.71
Debt / Equity
0.66
LT Debt / Equity
0.06
-
-
EPS (TTM)
559.85
EPS next Y
-
EPS next Q
-
EPS this Y
1645.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.98%
Revenue Q/Q
-28.81%
EPS Q/Q
1451.21%
-
-
-
-
SMA20
-2.65%
SMA50
2.58%
SMA100
-24.68%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.03%
Gross Margin
12%
Oper. Margin
1%
Profit Margin
2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3480.0-6300.0
52W High
-38.73%
52W Low
+10.92%
RSI
43
Rel Volume
0.34
Avg Volume
281.66K
Volume
95.23K
Perf Week
-2.89%
Perf Month
-6.2%
Perf Quarter
-25.63%
Perf Half Y
-24.02%
-
-
-
-
Beta
0.926
-
-
Volatility
52.81%, 118.79%
Prev Close
-2.53%
Price
3860
Change
-1.03%
003720.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.27K | 3.46K | 3.92K | 4.35K | 3.67K | |
| Net income per share | -55.69 | 33.86 | 102.42 | 31.98 | 558.23 | |
| Operating cash flow per share | 157.48 | 317.09 | 209.38 | 340.16 | 505.68 | |
| Free cash flow per share | -122.91 | 82.77 | -32.77 | -276.45 | 134.65 | |
| Cash per share | 26.56 | 96.36 | 155.39 | 349.45 | 360.23 | |
| Book value per share | 1.29K | 1.3K | 1.43K | 1.53K | 2K | |
| Tangible book value per share | 1.3K | 1.35K | 1.49K | 1.53K | 2.01K | |
| Share holders equity per share | 1.29K | 1.3K | 1.43K | 1.53K | 2K | |
| Interest debt per share | 1.07K | 968.48 | 1.1K | 1.6K | 1.34K | |
| Market cap | 33.92B | 88.2B | 101.96B | 80.38B | 150.21B | |
| Enterprise value | 69.05B | 117.92B | 133.96B | 122.47B | 182.46B | |
| P/E ratio | -17.92 | 76.64 | 29.29 | 73.96 | 8.06 | |
| Price to sales ratio | 0.31 | 0.75 | 0.77 | 0.54 | 1.23 | |
| POCF ratio | 6.34 | 8.18 | 14.33 | 6.95 | 8.9 | |
| PFCF ratio | -8.12 | 31.35 | -91.55 | -8.55 | 33.42 | |
| P/B Ratio | 0.78 | 2 | 2.09 | 1.55 | 2.25 | |
| PTB ratio | 0.78 | 2 | 2.09 | 1.55 | 2.25 | |
| EV to sales | 0.62 | 1 | 1.01 | 0.83 | 1.49 | |
| Enterprise value over EBITDA | 10.47 | 13.72 | 13.7 | 14.05 | 14.33 | |
| EV to operating cash flow | 12.9 | 10.94 | 18.82 | 10.59 | 10.81 | |
| EV to free cash flow | -16.53 | 41.92 | -120.28 | -13.03 | 40.59 | |
| Earnings yield | -0.06 | 0.01 | 0.03 | 0.01 | 0.12 | |
| Free cash flow yield | -0.12 | 0.03 | -0.01 | -0.12 | 0.03 | |
| Debt to equity | 0.81 | 0.74 | 0.76 | 1.04 | 0.66 | |
| Debt to assets | 0.33 | 0.3 | 0.31 | 0.4 | 0.33 | |
| Net debt to EBITDA | 5.33 | 3.46 | 3.27 | 4.83 | 2.53 | |
| Current ratio | 0.87 | 0.91 | 0.9 | 0.79 | 0.78 | |
| Interest coverage | -0.88 | 2.7 | 6.54 | 3.01 | 9.35 | |
| Income quality | -2.83 | 9.36 | 1.96 | 10.64 | 1.23 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.78 | -0.74 | -1.16 | -1.81 | -0.73 | |
| Capex to revenue | -0.09 | -0.07 | -0.06 | -0.14 | -0.1 | |
| Capex to depreciation | -1.3 | -1.15 | -1.23 | -3.1 | -1.86 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.27K | 994.4 | 1.82K | 1.05K | 5.01K | |
| ROIC | -0.01 | 0.03 | 0.04 | 0.01 | 0.06 | |
| Return on tangible assets | -0.02 | 0.01 | 0.03 | 0.01 | 0.14 | |
| Graham Net | -945.42 | -930.63 | -916.4 | -1.3K | -895.31 | |
| Working capital | -7.05B | -4.7B | -5.6B | -14.55B | -13.25B | |
| Tangible asset value | 44.3B | 45.74B | 50.54B | 51.98B | 67.08B | |
| Net current asset value | -17.24B | -17.29B | -15.83B | -28.74B | -17.17B | |
| Invested capital | 0.81 | 0.74 | 0.76 | 1.04 | 0.66 | |
| Average receivables | 29.48B | 28.73B | 29.38B | 27.28B | 22.86B | |
| Average payables | 9.96B | 10.97B | 13.1B | 13.4B | 13.17B | |
| Average inventory | 13.38B | 14.87B | 14.97B | 17.29B | 16.24B | |
| Days sales outstanding | 96.76 | 86.83 | 84.25 | 58.8 | 65.28 | |
| Days payables outstanding | 35 | 44.37 | 43.74 | 36.39 | 46.76 | |
| Days of inventory on hand | 55.08 | 52.65 | 48.3 | 54.19 | 46.04 | |
| Receivables turnover | 3.77 | 4.2 | 4.33 | 6.21 | 5.59 | |
| Payables turnover | 10.43 | 8.23 | 8.34 | 10.03 | 7.81 | |
| Inventory turnover | 6.63 | 6.93 | 7.56 | 6.74 | 7.93 | |
| ROE | -0.04 | 0.03 | 0.07 | 0.02 | 0.28 | |
| Capex per share | -280.39 | -234.32 | -242.15 | -616.6 | -371.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.02K | 1.01K | 994.56 | 952.35 | 684.83 | |
| Net income per share | -18.89 | 44 | 37 | 29 | 449.85 | |
| Operating cash flow per share | 336.8 | 35.55 | 141.5 | 115.6 | 211.79 | |
| Free cash flow per share | -281.91 | -133.76 | 69.43 | 48.14 | 153.22 | |
| Cash per share | 349.45 | 195.92 | 307.57 | 266.04 | 362.57 | |
| Book value per share | 1.53K | 1.55K | 1.53K | 1.57K | 2.01K | |
| Tangible book value per share | 1.53K | 1.56K | 1.54K | 1.58K | 2.02K | |
| Share holders equity per share | 1.53K | 1.55K | 1.53K | 1.57K | 2.01K | |
| Interest debt per share | 1.58K | 1.6K | 1.76K | 1.66K | 1.33K | |
| Market cap | 80.38B | 122.6B | 144.46B | 164.65B | 149.24B | |
| Enterprise value | 122.47B | 170.35B | 193.48B | 211.51B | 181.49B | |
| P/E ratio | -31.31 | 20.51 | 28.92 | 42.37 | 2.5 | |
| Price to sales ratio | 2.31 | 3.56 | 4.3 | 5.16 | 6.57 | |
| POCF ratio | 7.02 | 101.56 | 30.25 | 42.52 | 21.25 | |
| PFCF ratio | -8.39 | -26.99 | 61.65 | 102.1 | 29.37 | |
| P/B Ratio | 1.55 | 2.32 | 2.8 | 3.14 | 2.24 | |
| PTB ratio | 1.55 | 2.32 | 2.8 | 3.14 | 2.24 | |
| EV to sales | 3.52 | 4.95 | 5.76 | 6.63 | 7.99 | |
| Enterprise value over EBITDA | 167.29 | 51.71 | 51.35 | 51.59 | 36.42 | |
| EV to operating cash flow | 10.7 | 141.11 | 40.51 | 54.61 | 25.84 | |
| EV to free cash flow | -12.78 | -37.5 | 82.56 | 131.16 | 35.71 | |
| Earnings yield | -0.01 | 0.01 | 0.01 | 0.01 | 0.1 | |
| Free cash flow yield | -0.12 | -0.04 | 0.02 | 0.01 | 0.03 | |
| Debt to equity | 1.04 | 1.03 | 1.15 | 1.06 | 0.66 | |
| Debt to assets | 0.4 | 0.39 | 0.42 | 0.4 | 0.33 | |
| Net debt to EBITDA | 57.49 | 14.49 | 13.01 | 11.43 | 6.47 | |
| Current ratio | 0.79 | 0.73 | 0.74 | 0.71 | 0.78 | |
| Interest coverage | -150.93 | 33.72 | 4.78 | 5.22 | 22.51 | |
| Income quality | -17.83 | 0.72 | 3.84 | 3.56 | 0.7 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0.09 | 0.1 | 0 | |
| Research and developement to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.84 | -4.76 | -0.51 | -0.58 | -0.28 | |
| Capex to revenue | -0.6 | -0.17 | -0.07 | -0.07 | -0.09 | |
| Capex to depreciation | -12.62 | -3.42 | -1.52 | -1.36 | -1.13 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 805.02 | 1.24K | 1.13K | 1.01K | 4.51K | |
| ROIC | -0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Return on tangible assets | 0 | 0.01 | 0.01 | 0.01 | 0.11 | |
| Graham Net | -1.3K | -1.43K | -1.48K | -1.46K | -901.13 | |
| Working capital | -14.55B | -19.1B | -20.09B | -21.6B | -13.25B | |
| Tangible asset value | 51.98B | 53.07B | 51.87B | 52.92B | 67.08B | |
| Net current asset value | -28.74B | -32.17B | -31.98B | -31.76B | -17.17B | |
| Invested capital | 1.04 | 1.03 | 1.15 | 1.06 | 0.66 | |
| Average receivables | 25.67B | 24.85B | 25.87B | 25.97B | 24.02B | |
| Average payables | 12.16B | 12.89B | 13.1B | 14.46B | 14.45B | |
| Average inventory | 20.19B | 19.67B | 19.32B | 17.77B | 15.04B | |
| Days sales outstanding | 61.63 | 67.73 | 69.28 | 73.65 | 86.88 | |
| Days payables outstanding | 37.95 | 38.61 | 40.44 | 50.29 | 71.77 | |
| Days of inventory on hand | 56.52 | 60.33 | 56.24 | 54.78 | 70.66 | |
| Receivables turnover | 1.46 | 1.33 | 1.3 | 1.22 | 1.04 | |
| Payables turnover | 2.37 | 2.33 | 2.23 | 1.79 | 1.25 | |
| Inventory turnover | 1.59 | 1.49 | 1.6 | 1.64 | 1.27 | |
| ROE | -0.01 | 0.03 | 0.02 | 0.02 | 0.22 | |
| Capex per share | -618.71 | -169.31 | -72.07 | -67.47 | -58.56 |
003720.KS Frequently Asked Questions
What is SamYoung Chemical Co.,Ltd stock symbol ?
SamYoung Chemical Co.,Ltd is a KR stock and trading under the symbol 003720.KS
What is SamYoung Chemical Co.,Ltd stock quote today ?
SamYoung Chemical Co.,Ltd stock price is $3860 today.
Is SamYoung Chemical Co.,Ltd stock public?
Yes, SamYoung Chemical Co.,Ltd is a publicly traded company.
Company Profile
- Volume Average 281.66K
- Market Capitalization 133.32B
- Employee 176
- CEO Mr. Lee Seok Joon
- Headquarters Seoul,KR
- IPO Date 2000-01-04
-
Website
https://www.sycc.co.kr 
SamYoung Chemical Co.,Ltd manufactures and sells electronic and packaging films in South Korea. It offers PP films, such as BOPP films that are used in food and non-food packing materials, tapes, capacitors, etc.; CPP films; and vacuumed films for application in food packages, agrichemicals, medical products, sundries, stationaries, gift packings, etc., as well as nylon films for meat and meat processing vacuum packing, and agricultural/fishery/industrial vacuum packing. The company also provides capacitor films; and wraps, such as PE stretch films for packing electronic products, complicated machines and parts, various living household products, medical products, bricks, and other separable products, as well as PE bio wraps, PVC sun wraps, and antifungal sun wraps. In addition, it offers lamination products consisting of poly match and toothpaste films; and paper packing containers. The company exports its products to 40 countries. The company was founded in 1959 and is based in Seoul, South Korea.
